ETM
Euclidean Technologies Management’s Usana Health Sciences USNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-39,376
| Closed | -$2.09M | – | 95 |
|
|
2022
Q4 | $2.09M | Buy |
39,376
+15,829
| +67% | +$842K | 1.99% | 21 |
|
|
2022
Q3 | $1.32M | Hold |
23,547
| – | – | 1.48% | 45 |
|
|
2022
Q2 | $1.7M | Hold |
23,547
| – | – | 1.76% | 34 |
|
|
2022
Q1 | $1.87M | Hold |
23,547
| – | – | 1.73% | 39 |
|
|
2021
Q4 | $2.38M | Sell |
23,547
-1,885
| -7% | -$191K | 1.99% | 15 |
|
|
2021
Q3 | $2.35M | Hold |
25,432
| – | – | 2.04% | 14 |
|
|
2021
Q2 | $2.61M | Buy |
25,432
+459
| +2% | +$47K | 2.08% | 6 |
|
|
2021
Q1 | $2.44M | Hold |
24,973
| – | – | 2.12% | 15 |
|
|
2020
Q4 | $1.93M | Buy |
24,973
+3,005
| +14% | +$232K | 2.03% | 22 |
|
|
2020
Q3 | $1.62M | Buy |
21,968
+2,733
| +14% | +$201K | 2.04% | 13 |
|
|
2020
Q2 | $1.41M | Buy |
+19,235
| New | +$1.41M | 1.98% | 23 |
|
|
2016
Q1 | – | Sell |
-800
| Closed | -$102K | – | 64 |
|
|
2015
Q4 | $102K | Hold |
800
| – | – | 0.11% | 56 |
|
|
2015
Q3 | $107K | Sell |
800
-1,300
| -62% | -$174K | 0.11% | 53 |
|
|
2015
Q2 | $287K | Sell |
2,100
-19,408
| -90% | -$2.65M | 0.27% | 51 |
|
|
2015
Q1 | $2.39M | Sell |
21,508
-13,224
| -38% | -$1.47M | 2.18% | 18 |
|
|
2014
Q4 | $3.56M | Sell |
34,732
-18,668
| -35% | -$1.92M | 3.33% | 17 |
|
|
2014
Q3 | $3.93M | Buy |
53,400
+1,300
| +2% | +$95.7K | 3.66% | 3 |
|
|
2014
Q2 | $4.07M | Sell |
52,100
-4,600
| -8% | -$359K | 3.6% | 7 |
|
|
2014
Q1 | $4.27M | Buy |
56,700
+14,424
| +34% | +$1.09M | 3.74% | 4 |
|
|
2013
Q4 | $3.2M | Buy |
+42,276
| New | +$3.2M | 2.92% | 25 |
|